A Prospective, Active-controlled, Randomized, Double-blind, Multicenter, Phase III Study to Compare the Safety and Efficacy of Biosimilar Denosumab vs Reference Denosumab in the Treatment of Postmenopausal Osteoporosis.
Paul T, Garg B, Kapoor N, Patil V, Kachnerkar N, Shembalkar J, Purohit S, Maheshwari S, Maheshwari S, Yadav A, Cherian JJ, Agrawal A, Basu K, Tripathy SK, Pongde AB, Goni V, Markade P, Makane A, Tiwaskar M, Cherian KE, Rane Y, Shahavi V, Poojary V, Somani R, Gondane A, Aiwale A, Pawar D, Pawar R, Sharma A.
Paul T, et al. Among authors: tripathy sk.
J Assoc Physicians India. 2025 Jan;73(1):e8-e13. doi: 10.59556/japi.73.0772.
J Assoc Physicians India. 2025.
PMID: 39893524
Clinical Trial.